Skip to main content
Fig. 4 | Journal of Pharmaceutical Policy and Practice

Fig. 4

From: A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list

Fig. 4

Percentage of NEMLs from SADC with 2021 WHO EML recommended medicines for cardiovascular diseases. a–f Percentage of SADC NEMLs with 2021 WHO recommended medicines for angina, hypertension, arrhythmias, heart failure, thrombosis, hyperlipidaemia and CVD medicines for children. Figures are in order of indication in the 2021 WHO EML

Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us